Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis

Journal of Medical Microbiology

Volumn 51, Issue 7, 2002, Pages 539-547

  Atkins, Timothy ^a   Prior, Richard ^a   Mack, Kerri ^a   Russell, Paul ^a   Nelson, Michelle ^a   Prior, Joann ^a   Ellis, Jill ^a   Oyston, Petra C F ^a   Dougan, Gordon ^a   Titball, Richard W ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIAL KINETICS; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; BACTERIUM MUTANT; BURKHOLDERIA PSEUDOMALLEI; FEMALE; GENE INSERTION; IMMUNE RESPONSE; LETHAL DOSE; MOUSE; MUTAGENESIS; NONHUMAN; OPERON; PRIORITY JOURNAL; TRANSPOSON;

EID: 0036301434     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-51-7-539     Document Type: Article

References (58)

1. Melioidosis: Review and update
2. Melioidosis
3. Melioidosis survey in Kenya
4. Burkholderia pseudomallei and melioidosis: Be aware in temperate area
5. An indigenous melioidosis: A case report
6. Surgical presentation of melioidosis in India
7. Pathogenesis of and immunity to melioidosis
8. The pseudomallei group: A review
9. Melioidosis
10. Pseudomonas pseudomallei: Danger in the paddy fields
11. Burkholderia pseudomallei virulence: Definition, stability and association with clonality
12. Septicaemic melioidosis: A review of 50 cases from Malaysia
13. Toxins of Pseudomonas pseudomallei. 1. Production in vitro
14. Toxin produced by Malleomyces pseudomallei
15. Inhibition of macromolecular synthesis in cultured macrophages by Pseudomonas pseudomallei exotoxin
16. A competitive immunosorbent assay for detection of Pseudomonas pseudomallei exotoxin
17. Toxin production by Burkholderia pseudomallei strains and correlation with severity of melioidosis
18. Purification and characterization of a cytotoxic exolipid of Burkholderia pseudomallei
19. Production of hemolysin and other extracellular enzymes by clinical isolates of Pseudomonas pseudomallei
20. Separation of 6-deoxy-heptane from a smooth-type lipopolysaccharide preparation of Burkholderia pseudomallei
21. Detection of bacterial virulence genes by subtractive hybridisation: Identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant
22. Interaction of insulin with Pseudomonas pseudomallei
23. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence
24. Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant
25. Simultaneous identification of bacterial virulence genes by negative selection
26. Identification of Yersinia enterocolitica genes affecting survival in an animal host using signature-tagged transposon mutagenesis
27. Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis
28. Large-scale identification of virulence genes from Streptococcus pneumoniae
29. Identification of protease and rpoN-associated genes of uropathogenic Proteus mirabilis by negative selection in a mouse model of ascending urinary tract infection
30. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis
31. Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesis
32. Identification of genes required for chronic persistence of Brucella abortus in mice
33. Signature-tagged and directed mutagenesis identify PABA synthetase as essential for Aspergillus fumigatus pathogenicity
34. A simple method of estimating fifty percent endpoints
35. The detection of insertion sequences within the human pathogen Burkholderia pseudomallei which have been identified previously in Burkholderia cepacia
36. Lipopolysaccharide: Isolation and characterization
37. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
38. Rapid identification of Burkholderia pseudomallei by latex aggultination based on an exopolysaccharide-specific monoclonal antibody
39. Use of signature-tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization
40. Signature-tagged mutagenesis and the hunt for virulence factors
41. Identification of new genes involved in the virulence of Listeria monocytogenes by signature-tagged transposon mutagenesis
42. Polarity of Tn5 insertion mutations in Escherichia coli
43. Specificity of transposon Tn5 insertion
44. Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species
45. The histopathology of human meliodosis
46. Intracellular survival of Burkholderia pseudomallei
47. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei
48. Protease production by Burkholderia pseudomallei and virulence in mice
49. Type b capsule inhibits ingestion of Haemophilus influenzae by murine macrophages: Studies with isogenic encapsulated and unencapsulated strains
50. The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis
51. The capsule is a virulence determinant in the pathogenesis of Pasteurella multocida M1404 (B:2)
52. Human melioidosis: An emerging medical problem
53. Survival of Pseudomonas pseudomallei in human phagocytes
54. Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use as live vaccines
55. Construction and vaccine potential of acapsular mutants of Erysipelothrix rhusiopathiae: Use of excision of Tn916 to inactivate a target gene
56. Exopolysaccharides of Burkholderia pseudomallei